Transgene-design

Transgene-design designs mammalian transgenes by optimizing exonic synonymous-site GC content and modulating exonic splice enhancer (ESE) density to improve expression of human intronless transgenes and native retrogenes.


Key Features:

  • GC optimization: Optimizes GC content at exonic synonymous sites to increase expression efficiency of human intronless transgenes and native retrogenes.
  • ESE manipulation: Identifies and adjusts exonic splice enhancers (ESEs), allowing modulation of ESE density for intronless versus intron-containing contexts.
  • Input flexibility: Accepts native gene sequences or commercially optimized sequences as input for redesign.
  • First intron retention: Provides an option to retain the first intron within the gene sequence.
  • Motif protection and avoidance: Allows protection or avoidance of specified sequence motifs that may influence gene expression or stability.

Scientific Applications:

  • Gene expression regulation: Designs transgenes for experiments investigating determinants of mammalian gene expression.
  • Functional genomics: Enables construction of transgenes for functional genomics assays in mammalian systems.
  • Genetic engineering: Supports generation of optimized constructs for genetic engineering in mammalian cells.
  • Therapeutic development: Facilitates design of transgenes relevant to development of novel therapeutic strategies.

Methodology:

Optimizes exonic synonymous-site GC content, identifies and adjusts exonic splice enhancers (ESEs), offers first intron retention, protects or avoids specified motifs, and accepts native or commercially optimized input sequences.

Topics

Details

License:
GPL-3.0
Cost:
Free of charge
Tool Type:
web application
Operating Systems:
Mac, Linux, Windows
Programming Languages:
Ruby
Added:
6/28/2022
Last Updated:
11/24/2024

Operations

Publications

Mühlhausen S, Hurst LD. Transgene-design: a web application for the design of mammalian transgenes. Bioinformatics. 2022;38(9):2626-2627. doi:10.1093/bioinformatics/btac139. PMID:35244144. PMCID:PMC9048660.

PMID: 35244144
PMCID: PMC9048660
Funding: - European Research Council grant EvoGenMed: ERC-2014-ADG 669207

Links